Company Filing History:
3 out of 293 
3 out of 593 
Years Active: 2010-2018
Title: T Vincent Shankey: Innovator in Proteasome Inhibition and Signal Transduction
Introduction
T Vincent Shankey is a notable inventor based in Miami, FL (US). He has made significant contributions to the field of biochemistry, particularly in the development of assays that measure the effects of proteasome inhibitors and the activation of signal transduction pathways. With a total of 3 patents, his work has implications for both research and clinical applications.
Latest Patents
Shankey's latest patents include innovative methods and assays. One of his patents, titled "Proteasome inhibition assay and methods of use," provides assays that can measure the effect of proteasome inhibitors on target cells in a biological sample. These assays evaluate the effects of proteasome inhibitors on proteasome activity in cells. Another significant patent is "Pan-kinase activation and evaluation of signaling pathways," which offers methods and reagents for determining the activation state of signaling proteins in signal transduction pathways. This patent addresses the need for methods that can monitor the efficacy of signal transduction inhibitors in patients, particularly in cases where obtaining large cellular samples is challenging, such as in neonates.
Career Highlights
Throughout his career, T Vincent Shankey has worked with reputable organizations, including the University Health Network and Beckman Coulter, Inc. His experience in these institutions has allowed him to develop and refine his innovative approaches to biochemistry and molecular biology.
Collaborations
Shankey has collaborated with notable professionals in his field, including Sue Chow and David Hedley. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
T Vincent Shankey's contributions to the field of biochemistry through his innovative patents highlight his role as a significant inventor. His work in proteasome inhibition and signal transduction continues to impact both research and clinical practices.